Chalo, ab zara numbers ko aur detail mein dekhte hain. Shree Hari Chemicals Export Limited ne Q3 FY26 ke results nikale hain aur yeh kaafi disappointing hain. Standalone revenue ₹444.85 Cr raha, jo pichhle saal ke ₹1061.70 Cr se 58.09% kam hai. Aur agar QoQ ki baat karein toh revenue 40.27% gira hai. Profit bhi ghata, ₹90.36 Cr pe aa gaya, jo YoY basis par 76.98% neeche hai. Haalanki, QoQ basis par profit 31.17% badha hai.
Lekin asli magic/confusion aata hai EPS mein. Basic EPS ₹717 raha, jo pichhle saal se 20.50% zyada hai. Yeh kaise hua? Toh bhai, company ne Zero Coupon Compulsorily Convertible Debentures (CCDs) ko equity shares mein convert kar diya December 4, 2025 ko. Isse shares ki sankhya badh gayi aur existing profit ko zyada shares mein bantna pada, jisse EPS artificially badh gaya. Yeh asli operational improvement nahi, balki share dilution hai.
Consolidated numbers bhi lagbhag same hain. Consolidated Revenue ₹444.86 Cr raha, jo 58.09% YoY kam hai. Consolidated Net Profit (PAT) ₹87.76 Cr raha, jo 76.94% YoY neeche hai. Lekin yeh dekhna mazedaar hai ki consolidated PAT mein QoQ basis par 1394.21% ka zabardast jump dikha hai, ₹6.29 Cr se badhkar ₹87.76 Cr ho gaya. Yeh shayad pichhle quarter ka low base hone ki wajah se ho sakta hai.
Agar 9 mahine (Nine-Month) ki performance dekhein toh standalone revenue 34.95% YoY badha hai, lekin net profit 82.5% gira hai. Consolidated revenue bhi 34.95% badha, par consolidated PAT 78.82% YoY gira hai. Company ne koi future guidance nahi diya hai, jisse uncertainty aur badh gayi hai. Consolidated PAT margin bhi pichhle saal ke ~35.7% se girkar ~19.7% ho gaya hai. Overall, company ke saamne challenges dikh rahe hain aur investors ko careful rehne ki zaroorat hai.